References
- Bhat S. G., Vaidyanathan C. S. Involvement of 4-hydroxymandelic acid in the degradation of mandelic acid by Pseudomonas convexa. Journal of Bacteriology 1976; 127: 1108–1118
- Caldwell J., Hutt A. J. Methodology for the isolation and characterisation of conjugates of xenobiotic carboxylic acids. Progress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud. Taylor & Francis, London 1989; Vol. 9: 11–51
- Caldwell J., Winter S. M., Hutt A. J. The pharmacological and toxicological significance of the stereochemistry of drug disposition. Xenobiotica 1988; 18: 59–70
- Drummond L., Caldwell J., Wilson H. K. The metabolism of ethyl benzene and styrene to mandelic acid: stereochemical considerations. Xenobiotica 1989; 19: 199–207
- Garry R. C., Smith I. A. The urinary excretion of mandelic acid administered intravenously to cats. Biochemical Journal 1940; 34: 490–499
- Hegeman G. D., Rosenberg E. Y., Kenyon S. L. Mandelic acid racemase from Pseudomonas putida. Purification and properties of the enzyme. Biochemistry 1970; 9: 4029–4036
- Hutt A. J., Fournel S., Caldwell J. Application of a radial compression column to the high-performance liquid chromatographic separation of the enantiomers of some 2-arylpropionic acids as their diastereoisomeric S-1-(naphthen-1-yl)ethylamides. Journal of Chromatography Biomedical Applications 1986; 378: 409–418
- Jenner P., Testa B. The influence of stereochemical factors on drug disposition. Drug Metabolism Reviews 1973; 2: 117–184
- Jerina D. M., Sayer J. M., Yagi H., Van Bladeren P. J., Thakker D. R., Levin W., Chang R. L., Wood A. W., Conney A. H. Stereoselective metabolism of polycyclic aromatic hydrocarbons to carcinogenic metabolites. Microsomes and Drug Oxidations, A. R. Boobis, J. Caldwell, F. De Matteis, C. R. Elcombe. Taylor & Francis, London 1985; 310–319
- Kenyon G. L., Hegeman G. D. Mandelic acid racemase from Pseudomonas putida. Evidence favoring a carbanion intermediate in the mechanism of action. Biochemistry 1970; 9(21)4036–4043
- Kenyon G. L., Hegeman G. D. Mandelate racemase. Advances in Enzymology and Related Areas of Molecular Biology 1979; 50: 325–360
- Korn M., Wodarz R., Schoknecht W., Weichart H., Bayer E. Styrene metabolism in man: gas chromatographic separations of mandelic acid enantiomers in the urine of exposed persons. Archives of Toxicology 1984; 55: 55–63
- Langenbeck U., Mohring H. U., Hinney B., Spiteller M. Quinoxalinol derivatives of aliphatic 2-oxocarboxylic acids. Biomedical Mass Spectrometry 1977; 4: 197–202
- McMahon R. E., Sullivan H. R. The nature of the in vivo conversion of L(—)methylphenylcarbinol to D(—)mandelic acid in the rat. Pharmacologist 1968; 10: 203
- Montenbruck D. Beitrag zum Abbau der α-Amino sauren: uber das Verhalken der Mandelsaure im organismus. Archiv fuer Experimentelle Pathologie und Pharmakologie 1940; 195: 164–167
- Quick A. J. Quantitative studies of β-oxidation. II. The metabolism of phenylvaleric acid, phenyl-α,β-pentenic acid, phenyl-β,γ-pentenic acid, mandelic acid, phenyl-β-hydroxy-propionic acid and acetophenone in dogs. Journal of Biological Chemistry 1928; 80: 515–526
- Sullivan H. R., Miller W. M., McMahon R. E. Reaction pathways of in vivo stereoselective conversion of ethylbenzene to (—) mandelic acid. Xenobiotica 1976; 6: 49–54
- Van Bladeren P. J., Balani S. K., Sayer J. M., Thakker D. R., Boyd D. R., Ryan D. E., Thomas P. E., Levin W., Jerina D. M. Stereoselective formation of benzo(c)phenanthrene (+)-(3S,4R) and (+)-(5S,6R)-oxides by cytochrome P450c in a highly purified and reconstituted system. Biochemical and Biophysical Research Communications 1987; 145: 160–167
- White R. E., Miller J. P., Favreau L. V., Bhattacharyya A. Stereochemical dynamics of aliphatic hydroxylation by cytochrome P-450. Journal of the American Chemical Society 1986; 108: 6024–6031
- Whitman C. P., Hegeman G. D., Cleland W. W., Kenyon G. L. Symmetry and asymmetry in mandelate racemase catalysis. Biochemistry 1985; 24: 3936–3942
- Wrede F. The synthesis of α-amino acids in the organism. Pharmazeutische Industrie (Berlin) 1938; 15(7)401–404